BE904921A - Procedes et compositions pour le traitement de troubles gastro-intestinaux. - Google Patents

Procedes et compositions pour le traitement de troubles gastro-intestinaux.

Info

Publication number
BE904921A
BE904921A BE0/216782A BE216782A BE904921A BE 904921 A BE904921 A BE 904921A BE 0/216782 A BE0/216782 A BE 0/216782A BE 216782 A BE216782 A BE 216782A BE 904921 A BE904921 A BE 904921A
Authority
BE
Belgium
Prior art keywords
treatment
compositions
methods
gastrointestinal disorders
question
Prior art date
Application number
BE0/216782A
Other languages
English (en)
Original Assignee
Marshall Barry J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marshall Barry J filed Critical Marshall Barry J
Publication of BE904921A publication Critical patent/BE904921A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procédé pour le traitement d'un etre humain ou d'un animal inférieur souffrant d'un trouble gastrointestinal, caractérisé en ce que l'on administre au sujet en question d'environ 50 mg à environ 5000g de bismuth, par jour, pendant une durée de 3 à 56 jours et on administre au sujet en question une quantité sure et efficace d'un agent antimicrobien par jour, pendant une période qui fluctue de 1 à 21 jours.
BE0/216782A 1985-06-13 1986-06-13 Procedes et compositions pour le traitement de troubles gastro-intestinaux. BE904921A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74484185A 1985-06-13 1985-06-13

Publications (1)

Publication Number Publication Date
BE904921A true BE904921A (fr) 1986-12-15

Family

ID=24994175

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/216782A BE904921A (fr) 1985-06-13 1986-06-13 Procedes et compositions pour le traitement de troubles gastro-intestinaux.

Country Status (11)

Country Link
EP (3) EP0206625B1 (fr)
JP (1) JPH0794390B2 (fr)
AT (3) ATE135582T1 (fr)
AU (1) AU588601B2 (fr)
BE (1) BE904921A (fr)
CA (1) CA1277232C (fr)
DE (4) DE3650504T2 (fr)
IE (1) IE59583B1 (fr)
NZ (1) NZ216516A (fr)
PH (1) PH25288A (fr)
ZA (1) ZA864449B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222834A4 (fr) * 1985-04-18 1989-10-04 Borody Thomas J Traitement de la dyspepsie non ulcereuse avec des sels de bismuth.
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
EP0282132B1 (fr) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions et leur utilisation dans le traitement d'affections gastrointestinales
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
US5196205A (en) * 1987-10-12 1993-03-23 Borody Thomas J Method for treatment of gastro intestinal disorders
GB8817098D0 (en) * 1988-07-18 1988-08-24 Glaxo Group Ltd Chemical compounds
EP0363502B1 (fr) * 1988-10-08 1991-09-25 Dr. R. Pfleger Chemische Fabrik Gmbh Formulation liquide contenant du bismuth, procédé pour la préparer et son utilisation
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
EP0375068A1 (fr) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Associations de composés de bismuth et de tétracyclines
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
FI910088L (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
BR9206300A (pt) * 1991-07-24 1994-08-02 Procter & Gamble Processos e composições de tratamento antimicrobiano
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
AU7833194A (en) * 1993-09-20 1995-04-10 Procter & Gamble Company, The Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection
US5549911A (en) * 1994-01-14 1996-08-27 Laboratoires Des Produits Ethiques Ethypharm Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
FR2715067B1 (fr) * 1994-01-14 1996-04-05 Ethypharm Lab Prod Ethiques Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal.
GB2293323A (en) * 1994-09-12 1996-03-27 Orion Yhtymae Oy Antibiotics and bismuth salts for treating bacterial infections
GB2292884A (en) * 1994-09-12 1996-03-13 Orion Yhtymae Oy Rifamycin & bismuth salts for treating bacterial infections
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease
PE48297A1 (es) * 1995-05-09 1998-02-04 Procter & Gamble Metodos y composiciones para la prevencion y el tratamiento de desordenes gastrointestinales
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US6051604A (en) * 1995-12-07 2000-04-18 The Proctor & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5702729A (en) * 1995-12-07 1997-12-30 The Procter & Gamble Company Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
US6067989A (en) * 1997-02-26 2000-05-30 Oridion Medical, Ltd. Breath test for the diagnosis of Helicobacter pylori infection in the gastrointestinal tract
US6186958B1 (en) 1997-02-26 2001-02-13 Oridion Medical Breath test analyzer
USRE38728E1 (en) * 1997-09-11 2005-04-19 Oridion Medical, LTD Breath test analyzer
CA2321265C (fr) * 1998-02-24 2009-10-13 Kaneka Corporation Compositions antibacteriennes a effet synergique, medicaments et remedes pour troubles digestifs contenant ces compositions, procede de production de ces compositions et preparations connexes
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
CN104666429A (zh) * 2013-11-28 2015-06-03 天津瑞贝特科技发展有限公司 治疗鸡腺胃炎的组合物及其制备方法
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1332522A (fr) * 1961-10-05 1963-07-19 Procédé pour préparer des composés résultant de la combinaison chimique de substances antibiotiques et de substances mycocides
US3395212A (en) * 1964-08-10 1968-07-30 American Cyanamid Co Neomycin and organobismuth antibacterial finish for cellulosic material
FR6531M (fr) * 1967-09-14 1968-12-09
US4153685A (en) * 1968-11-23 1979-05-08 Schering Corporation Bismuth complex preparations
FR2053002A1 (en) * 1969-06-21 1971-04-16 Clin Midy Bismuth slats of alpha methiminobenzyl - penicillin
DE1963496A1 (de) * 1969-12-18 1971-06-24 Hans Voigt Chemisch Pharmazeut Pharmazeutisches Praeparat zur Behandlung von Magen-Darm-Erkrankungen
US4118480A (en) * 1973-02-09 1978-10-03 Charles V. Stoelker Pharmaceutical preparation for treating hemorrhoids and anal fissures
US3903297A (en) 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions
US4016268A (en) * 1975-10-06 1977-04-05 Morton-Norwich Products, Inc. Method of combatting gastric ulceration
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4588589A (en) * 1983-10-13 1986-05-13 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
EP0222834A4 (fr) * 1985-04-18 1989-10-04 Borody Thomas J Traitement de la dyspepsie non ulcereuse avec des sels de bismuth.

Also Published As

Publication number Publication date
DE3686836D1 (de) 1992-11-05
IE861572L (en) 1986-12-13
DE3650787T2 (de) 2006-11-16
DE3686836T2 (de) 1993-03-04
EP0206625A2 (fr) 1986-12-30
JPH0794390B2 (ja) 1995-10-11
DE3650787D1 (de) 2006-04-27
ATE318144T1 (de) 2006-03-15
NZ216516A (en) 1989-08-29
AU5859586A (en) 1986-12-18
DE3619702A1 (de) 1987-02-12
ZA864449B (en) 1987-02-25
EP0707854A2 (fr) 1996-04-24
EP0462631A1 (fr) 1991-12-27
IE59583B1 (en) 1994-03-09
DE3650504T2 (de) 1996-10-31
ATE81010T1 (de) 1992-10-15
ATE135582T1 (de) 1996-04-15
AU588601B2 (en) 1989-09-21
DE3650504D1 (de) 1996-04-25
EP0206625A3 (en) 1989-04-05
EP0462631B1 (fr) 1996-03-20
EP0707854A3 (fr) 1997-06-04
PH25288A (en) 1991-04-30
EP0707854B1 (fr) 2006-02-22
JPS6248623A (ja) 1987-03-03
CA1277232C (fr) 1990-12-04
EP0206625B1 (fr) 1992-09-30

Similar Documents

Publication Publication Date Title
MA22914A1 (fr) Methodes pour traiter l'arthrite a l'aide de phosphonates et d'ains.
BR8203384A (pt) Sistema para tratamento do sangue de um paciente
IT9048260A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
JPS57179120A (en) Application of snake poison for treatment of nervous system or related diseases
BE901667A (fr) Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation.
FR2509613B1 (fr) Medicament a base d'insuline pour le traitement du diabete sucre
IT9048261A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
DK505584A (da) Administrationssaet og farmaceutiske praeparater til anvendelse dertil
FR2712495B1 (fr) Application de l'Óoenotheine B pour obtenir un médicament destiné au traitement des troubles liés à l'hyperandrogénie, et les compositions pharmaceutiques le contenant.
DZ452A1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine et du c-paptide humain.
FR2601030B1 (fr) Compositions acides a hautes concentrations en matieres actives pour le traitement des eaux et/ou le nettoyage des installations les contenant
FR2518372B2 (fr) Composition alimentaire, utile notamment pour les diabetiques, et son application dans le traitement des troubles du metabolisme glucidique
BE894186A (fr) Formulations pharmaceutiques de pro-insuline humaine
FR2585953B1 (fr) Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede
FR2620931B1 (fr) Dispositif et procede pour le traitement d'affections des gencives
BE904146A (fr) Compositions pharmaceutiques a base de 3-aminopropoxyindoles.
NO982634L (no) Sammensetninger inneholdende vismut og ett eller flere antimikrobielle midler for forebygging og behandling av gastrointestinale forstyrrelser
BR9612123A (pt) Composições contendo bismuto e um ou mais antimicrobianos para a prevenção de desordens gastrointestinais
NO982632D0 (no) Sammensetninger inneholdende vismut for forebygging og behandling av gastrointestinale forstyrrelser
EP0717625A4 (fr) Methode de traitement de maladie hepatique et d'indications analogues au moyen d'agents vasodilatateurs
IT8719390A0 (it) Composizione farmaceutica per la prevenzione e il trattamento dell'aterosclerosi.
EP0576914A3 (fr) 14-Désoxy-14-alpha-cardénolied-3-bèta-thiodérivés et compositions pharmaceutiques les contenant pour le traitement des troubles cardiovasculaires.
DK39584A (da) Anvendelse af nafazatrom til forebyggelse og behandling af diverse sygdomme, laegemidler indeholdende nafazatrom samt fremgangsmaader til disses fremstilling
PT67907A (fr) Procede pour la preparation de 2'-hydroxy-2 d'addition d'acides et compositions pharmaceutiques qui les contiennent.
IT8148480A0 (it) Composizione terapeutica e sistema per il trattamento extracorporeo di sangue intero

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *MARSHALL BARRY J.

Effective date: 20060613